Writtle University College and ARU have merged. Writtle’s full range of college, degree, postgraduate and short courses will still be delivered on the Writtle campus. See our guide to finding Writtle information on this site.


One person reading a book and another person playing guitar; wording 'Homeside - partnership in dementia care' underneath

Music and reading for people with dementia and their caregivers

Homeside is an international research study across five countries: the UK, Australia, Germany, Norway and Poland. The project is evaluating home-based music and reading for people with dementia and their family (or informal) caregivers.

The research is being led by Professor Felicity Baker at The University of Melbourne and, in the UK, by Professor Helen Odell-Miller OBE, Director of Cambridge Institute for Music Therapy Research at Anglia Ruskin University.

What we're doing

Homeside will investigate the effects of music and reading for people living with dementia and their caregivers. We will train caregivers to deliver music or reading activities with the person they are caring for. The activities aim to decrease behavioural and psychological symptoms of dementia, as well as improve the quality of life and wellbeing of people living with dementia and their caregivers.

How you can get involved

We're looking for people with dementia and family (or informal) caregivers to take part.

On these pages, you can find out more about the study and how to get involved.

Funding and registration

The Homeside study is funded by the EU’s JPND research programme, which includes joint financial support from:

  • Alzheimer’s Society in the United Kingdom
  • National Health and Medical Research Council in Australia
  • Federal Ministry of Education and Research in Germany
  • Norwegian Research Council in Norway
  • National Centre for Research and Development in Poland.
Homeside is registered with two international registries for clinical research studies:
  • Australian New Zealand Clinical Trials Registry (ANZCTR): Identification number ACTRN12618001799246
  • ClinicalTrials.gov: identification number NCT03907748

We have received ethics approval from the NHS Research Ethics Committee.

  • IRAS project ID number: 260067.
  • Research Ethics Committee reference number: 19/EE/0177.